Organogenesis Holdings (ORGO) Non-Current Debt (2017 - 2024)
Organogenesis Holdings (ORGO) posted quarterly Non-Current Debt of $56.2 million for Q3 2024, down 9.6% year-over-year from $62.1 million in Q4 2023, and down 2.73% quarter-over-quarter from $57.7 million in Q2 2024.
Organogenesis Holdings (ORGO) Non-Current Debt (2017 - 2024) Analysis & Trends
Organogenesis Holdings' Non-Current Debt history runs 8 years deep, the most recent figure standing at $56.2 million for Q3 2024.
- In Q3 2024, Non-Current Debt fell 9.6% year-over-year to $56.2 million; the TTM figure through Sep 2024 stood at $56.2 million (down 9.6% YoY), while the FY2023 annual figure was $60.7 million, down 8.28% from the prior year.
- Non-Current Debt for Q3 2024 stood at $56.2 million, down from $57.7 million in the prior quarter.
- The five-year high for Non-Current Debt was $74.5 million in Q3 2021, with the low at $10.0 million in Q1 2020.
- The 5-year median for Non-Current Debt is $62.1 million (2023), against an average of $57.2 million.
- The sharpest annual moves came in 2020 and 2021: Non-Current Debt plunged 75.0% in 2020, then surged 328.76% in 2021.
- Organogenesis Holdings' Non-Current Debt stood at $43.0 million in 2020, then jumped by 64.41% to $70.8 million in 2021, then declined by 6.41% to $66.2 million in 2022, then slipped by 8.28% to $60.7 million in 2023, then slipped by 7.56% to $56.2 million in 2024.
- Business Quant data shows ORGO's Non-Current Debt at $56.2 million in Q3 2024, $57.7 million in Q2 2024, and $59.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 130.00 Mn |
| 10 | Organogenesis Holdings | 240.62 Mn | 193.78 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 56.15 Mn |
| Jun 30, 2024 | 57.73 Mn |
| Mar 31, 2024 | 59.37 Mn |
| Dec 31, 2023 | 60.75 Mn |
| Sep 30, 2023 | 62.12 Mn |
| Jun 30, 2023 | 63.49 Mn |
| Mar 31, 2023 | 64.86 Mn |
| Dec 31, 2022 | 66.23 Mn |
| Sep 30, 2022 | 67.60 Mn |
| Jun 30, 2022 | 68.97 Mn |
| Mar 31, 2022 | 69.87 Mn |
| Dec 31, 2021 | 70.77 Mn |
| Sep 30, 2021 | 74.53 Mn |
| Jun 30, 2021 | 70.00 Mn |
| Mar 31, 2021 | 42.88 Mn |
| Dec 31, 2020 | 43.04 Mn |
| Sep 30, 2020 | 39.35 Mn |
| Jun 30, 2020 | 39.35 Mn |
| Mar 31, 2020 | 10.00 Mn |
| Dec 31, 2019 | 33.48 Mn |